Skip to main content
. 2023 Aug 7;15(15):3486. doi: 10.3390/nu15153486

Table 2.

Diseases, medication intake, and characteristics of the last pregnancy recorded for the donors (n = 114).

n (%)
Diseases 1 41 (36.0%)
Endocrinological and metabolic diseases * 10 (8.8%)
Cardiovascular diseases (hypertension) 1 (0.9%)
Respiratory diseases (asthma) 6 (5.3%)
Immune diseases (allergy, psoriasis, atopy) 7 (6.1%)
Spinal/medullary pathology 6 (5.3%)
Miscellaneous ** 13 (11.4%)
Medication intake 1 12 (10.5%)
Oral contraceptives 4 (3.5%)
Thyroid hormone replacement therapy 4 (3.5%)
Other medicines *** 5 (4.4%)
Twin pregnancy 4 (3.5%)
Problems in the last pregnancy 1 36 (31.6%)
Thyroid disorders 17 (14.9%)
Preeclampsia 2 (1.8%)
Gestational diabetes 2 (1.8%)
Intrauterine fetal growth restriction 6 (5.3%)
Intrauterine fetal death 3 (2.6%)
Other problems **** 11 (9.6%)

1 The categories do not exclude each other. * Endocrinological and metabolic diseases included four cases of well-controlled hypothyroidism, four cases of subclinical thyroid disorders, and two cases of hypercholesterolemia. ** Miscellaneous included congenital amylase–sucrase deficiency, fatty liver, esophagitis, antiphospholipid syndrome, uveitis, migraines, polycystic ovary syndrome, cholesteatoma, venous insufficiency, recurrent urinary tract infections, human papillomavirus infection, and depression. *** Other medicines included antihistamines, antidepressants, proton-pump inhibitors, antivertiginous medications, and oral bronchodilators. **** Other problems included the threat of abortion, threat of premature birth, feto-fetal transfusion syndrome, chorioamnionitis, oligohydramnios, intrahepatic cholestasis, cytomegalovirus infection, bronchitis, and urinary tract infections.